Nature Communications (May 2019)

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice

  • Wenwen Yue,
  • Liang Chen,
  • Luodan Yu,
  • Bangguo Zhou,
  • Haohao Yin,
  • Weiwei Ren,
  • Chang Liu,
  • Lehang Guo,
  • Yifeng Zhang,
  • Liping Sun,
  • Kun Zhang,
  • Huixiong Xu,
  • Yu Chen

DOI
https://doi.org/10.1038/s41467-019-09760-3
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

Immunotherapy for the treatment of cancer can be complicated by side effects and poor efficacy. Here, the authors use a nanoparticle-based approach in combination with a TLR7 agonist and sonodynamic therapy, and find that when used together with anti-PD-L1, tumour formation and metastases are impacted.